Contract 75N93024C00020
Children'S Hospital Corporation, The · Department Of Health And Human Services · September 19, 2024
Children'S Hospital Corporation, The was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 19, 2024 for $2.55 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost no fee contract pricing. The most recent modification was on September 26, 2025. If all options are exercised, the contract could reach $7.53 million.
Contract details
- PIID
- 75N93024C00020
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Boston, MA
- First action
- September 19, 2024
- Latest action
- September 26, 2025
Description
EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)
Modification timeline
-
September 26, 2025Mod P00003 · Change Order$2.55M
-
July 1, 2025Mod P00002 · Supplemental Agreement For Work Within ScopeVACCINE ADJUVANT DISCOVERY PROGRAM (VADP)$1.44M
-
September 19, 2024Base awardVACCINE ADJUVANT DISCOVERY PROGRAM (VADP)$1.44M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93024C00020?
Contract 75N93024C00020 is a federal contract awarded to Children'S Hospital Corporation, The by Department Of Health And Human Services on September 19, 2024 for $2.55 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75N93024C00020?
Children'S Hospital Corporation, The won contract 75N93024C00020 from Department Of Health And Human Services.
How much is contract 75N93024C00020 worth?
Contract 75N93024C00020 has obligated $2.55 million to date, with a total potential value of $7.53 million if all options are exercised.